Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.22 USD | -1.07% | -15.41% | -34.28% |
05-08 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.28% | 515M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+42.95% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- HC Wainwright Adjusts Price Target on Olema Pharmaceuticals to $15 From $12, Keeps Buy Rating